Top FDA vaccine official Peter Marks resigns, citing misinformation by HHS Secretary Kennedy. Learn the impact on public ...

We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

CureVac N.V. secured funding with GSK amid financial struggles, while a key patent win boosts stock. Click for why my ...

Pre-specified interim analysis of Phase 3 PIVOT-PO clinical trial of tebipenem HBr in complicated urinary tract infection (cUTI) is expected to ...

Merck signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion.

Harvey Jones has spotted signs of life in the GSK share price. Which is a relief after its recent troubles, so can the FTSE ...

Our writer Ken Hall evaluates two defensive dividend payers in the FTSE 100 that he thinks investors should consider buying ...

Pfizer has officially kissed goodbye to its consumer health venture by selling its final 7.3% stake in Haleon for a tidy $3.3 ...

PrimeC is NeuroSense's lead drug candidate for ALS, a novel extended-release oral formulation combining ciprofloxacin and celecoxib. The drug has demonstrated promising results in clinical trials, ...

This year's gearing up to be a wild ride for stocks and shares so investors should consider a careful approach to their ISA ...

Show Full Article The main part of their brain that is damaged is ... Between 6 per cent and 17 per cent of people with RLS who take dopamine agonists develop some form of impulse-control disorder, ...

Here are the dates for the full moons in 2025. The next full moon will be on Saturday, April 12. It will officially reach its full moon phase at 8:22 p.m. EDT (0022 GMT April 13), but local ...